These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21890808)

  • 1. Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
    Mukherji EH; Bauer LK; Leskov I; Januzzi JL; Tanev KS
    Am J Psychiatry; 2011 Sep; 168(9):990-1. PubMed ID: 21890808
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of QTc interval and antipsychotics.
    Su KP; Chang HC; Shen WW
    Am J Psychiatry; 2002 Jun; 159(6):1062-3; author reply 1064. PubMed ID: 12042204
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
    Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
    Leo R; Razzini C; Di Lorenzo G; Bianchi F; Tesauro M; Zanasi M; Siracusano A; Romeo F
    J Clin Psychiatry; 2008 Feb; 69(2):327-8. PubMed ID: 18363460
    [No Abstract]   [Full Text] [Related]  

  • 5. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
    Vieta E; Bourin M; Sanchez R; Marcus R; Stock E; McQuade R; Carson W; Abou-Gharbia N; Swanink R; Iwamoto T;
    Br J Psychiatry; 2005 Sep; 187():235-42. PubMed ID: 16135860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotic pharmacotherapy for delirious syndromes - only temporary, symptom-oriented and considering QTc time].
    Schwerthöffer D; Förstl H; Fatke B
    MMW Fortschr Med; 2019 Jul; 161(Suppl 5):1-6. PubMed ID: 31313266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.
    Muzyk AJ; Rayfield A; Revollo JY; Heinz H; Gagliardi JP
    Drug Saf; 2012 Jul; 35(7):547-53. PubMed ID: 22702639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drugs and QT interval prolongation.
    Zareba W; Lin DA
    Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of antipsychotics used in bipolar illness.
    Piepho RW
    J Clin Psychiatry; 2002; 63 Suppl 4():20-3. PubMed ID: 11913671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    Greco KE; Tune LE; Brown FW; Van Horn WA
    J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of alcohol delirium can cause sudden cardiac death].
    Pohjola-Sintonen S; Metsäniitty J
    Duodecim; 1997; 113(13):1286-7. PubMed ID: 10622135
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
    Teng PR; Shen TY; Lai TJ
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253
    [No Abstract]   [Full Text] [Related]  

  • 15. Probable Acquired QTc Prolongation and Subsequent Torsades de Pointes Attributable to Quetiapine.
    Giancaterino S; Solimine S
    Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29190419
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
    Taylor D
    CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of QTc interval and antipsychotics.
    Taylor DM
    Am J Psychiatry; 2002 Jun; 159(6):1062; author reply 1064. PubMed ID: 12042205
    [No Abstract]   [Full Text] [Related]  

  • 19. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 20. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.